Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Moyo, Sabrina J ^a   Aboud, Said ^a   Kasubi, Mabula ^b   Lyamuya, Eligius F ^a   Maselle, Samuel Y ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; KLEBSIELLA;

EID: 78650467514     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-348     Document Type: Article

References (23)

1. Treatment of urinary tract infection: what's old, what's new, and what works. CM Gonzalez AJ Schaeffer, World J Urol 1999 17 372 382 10.1007/s003450050163 10654368
2. Approach to the patient with urinary tract infection. WE Stamm AE Stapleton, Infectious Diseases Philadelphia: WB Saunders, Gorbach SL, Barlett JG, Blacklow NR, 2 1998 1270 1272
3. Antimicrobial resistance among uropathogens that cause community acquired urinary tract infections in women. A nationwide analysis. K Gupta DF Sahm D Mayfield WE Stamm, Clin Infect Dis 2001 33 89 94 10.1086/320880 11389500
4. Activity and spectrum of 22 antimicrobial agents tested against urinary tract pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998). AC Gales RN Jones KA Gordon HS Sader WW Wilke ML Beach MA Pfaller GV Doern, J Antimicrob Chemother 2000 45 295 303 10.1093/jac/45.3.295 10702547
5. Evaluation of extended spectrum beta lactamase in urinary isolates. SS Tankhiwale SV Jalgaonkar S Ahamad U Hassani, Indian J Med Res 2004 120 553 556 15654142
6. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. A Mohammed S Mohammed UK Asad, Ann Clin Microbiol Antimicrob 2007 6 4 10.1186/1476-0711-6-4 17378940
7. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. DT Steinke RA Seaton G Phillips TM MacDonald PG Davey, J Antimicrob Chemother 2001 47 781 787 10.1093/jac/47.6.781 11389110
8. AmpC disk test for detection of plasmid-mediated AmpC-b lactamases in Enterobacteriaceae lacking chromosomal AmpC-b lactamases. JA Black ES Moland KS Thomson, J Clin Microbiol 2005 43 3110 3113 10.1128/JCM.43.7.3110-3113.2005 16000421
9. The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. AR Manges P Natarajan OD Solberg PS Dietrich LW Riley, Epidemiol Infect 2006 134 425 431 10.1017/S0950268805005005 16490149
10. High rate of fatal cases of pediatric caused by gram-negative bacteria with extended-spectrum betalactamases in Dar es Salaam, Tanzania. B Blomberg R Jureen KP Manji BS Tamim DS Mwakagile WK Urassa M Fataki V Msangi MG Tellevik SY Maselle N Langeland, J Clin Microbiol 2005 43 745 749 10.1128/JCM.43.2.745-749. 2005 15695674
11. Extended Spectrum -Lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania. F Ndugulile R Jureen S Harthug W Urassa N Langeland, BMC Infect Dis 2005 5 86 10.1186/1471-2334-5-86 16225701
12. Murray Baron Pfaller Tenover, Manual of Clinical Microbiology American Society of Microbiology Press, Washington DC 6 1999
13. Clinical and Laboratory Standards Institute, Ninth edition Document M2-A9 Clinical and Laboratory Standards Institute, Wayne, PA; Performance standards for antimicrobial disk susceptibility tests. Approved standard 2006
14. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in Sudan. AA Ahmed H Osman AM Mansour HA Musa AB Ahmed Z Karrar HS Hassan, Am J Trop Med Hyg 2000 63 259 263 11421374
15. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Bangui, Central African Republic. H Hima-Lerible D Ménard A Talarmin, J Antimicrob Chemother 2003 51 192 194 10.1093/jac/dkg053 12493816
16. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. HS Khanfar KM Bindayna AC Senok GA Botta, J Infect Dev Ctries 2009 3 295 299 19759493
17. Antibiotic policy and prescribing strategies for therapy of extended-spectrum -lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. LR Peterson, Clin Microbiol Infect 2008 1 181 184 10.1111/j.1469-0691.2007.01864.x (Pubitemid 350269200)
18. High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. H Mehrgan Z Arab-Halvaii, J Infect Dev Ctries 2010 4 132 138 10.3855/jidc.488 20351452
19. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. A Alhambra JA Cuadros J Cacho JL Gámez-Garcés JI Alás, J Antimicrob Chemother 2004 53 1090 1094 10.1093/jac/dkh218 15117925
20. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. GW Procop MJ Tuohy DA Wilson D Williams E Hadziyannis GS Hall, Am J Clin Pathol 2003 120 265 267 10.1309/BWQKWB2WN6W5X1CC 12931557
21. Resistance in Gram-negative bacteria: Enterobacteriaceae. DL Paterson, Am J infect control 2006 34 20 28 10.1016/j.ajic.2006.05.238 (Pubitemid 43928183)
22. Ertapenem Resistance of Escherichia coli. MF Lartigue L Poirel C Poyart H Réglier-Poupet P Nordmann, Emerg Infect Dis 2007 13 315 317 10.3201/eid1302.060747 17479901
23. Frequency and sensitivity pattern of Extended Spectrum Beta Lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. K Jabeen A Zafar R Hasan, J Pak Med Assoc 2005 55 436 439 16304852